The alpha, twice a week
That was 3 min.
Get the best new moments in your inbox every Wednesday and Saturday. It's free.
Check your inbox
We sent a link to your address. Click it to finish signing up. Not there in a minute? Look in spam.
or
How I Invest · 3 min · Nov 16, 2026
Later-stage venture can offer attractive risk-adjusted returns
Renee Hanna says Baylor has moved from almost no later-stage exposure to finding some deals more attractive.
The episode’s best minutes
Full analysis- 5:50Expansion capital can compound more reliably than early venture3 min
- 13:24A concentrated portfolio helps Baylor focus capital and timePro pick 6 min
- 49:31Later-stage venture can offer attractive risk-adjusted returns3 min
- 5 more moments in the full episode
“we're very happy to jump in at a point where you have product market fit. It's been derisked.”
Takeaways
- Baylor previously held close to zero in later-stage venture.
- Hanna cites a 75x return for investors who entered SpaceX in 2017.
- A shorter path to a derisked return can make later entry worthwhile.
About this segment
Renee Hanna says Baylor has moved from almost no later-stage exposure to finding some deals more attractive. Product-market fit and shorter holding periods can make a 3–5x return compelling without betting on a first mover.
Renee Hanna is a Managing Director of Investments at Baylor University.
Oversees Baylor’s private investments across categories and geographies, bringing nearly two decades of endowment experience.

David Weisburd, Host
From “Baylor Endowment on Rethinking Venture Capital, Concentrated Portfolios, and Power of Compounding”, Nov 16, 2026. Watch the full episode
Thanks. We'll look at and fix what's off.
Transcript
From the transcript How I Invest publishes with the episode.
- 49:44
Probably, how much of our portfolio should be in later stage. And I'm not saying we're piling in at these prices, but effectively before, it was pretty close to zero. And I think now we just got the TAM wrong in some of these outcomes. And so thinking about the room to run and the ability to get a acceptable return, which is three to five x for us in three to five years, and some of these later stage outcomes with visibility and product market fit and growth rates.
- 50:17
That's been an area that we've found more attractive of late. I think people are still trying to digest the sticker shock of these IPOs. SpaceX, 1,750,000,000,000. Anthropic, reportedly 2,000,000,000,000. And they think that these are gonna be the largest companies. OpenAI as well is is in the running, reportedly raising at 1,250,000,000,000. And if that's the case, then there's a chance that these are the three best companies of the next ten, twenty years.
- 50:48
There's certainly a chance for that. But historically, that has not been the case. Google was, like, the twelfth or thirteenth search engine. Facebook was also in the teens. Even going back to to the original .com, Amazon was, I don't know, hundreds and hundreds of retailers. They were not the first movers. So it's very uncommon in a technological cycle that the best... The biggest winners are early.
- 51:13
It's never happened before. So I think if you believe that and if you're bullish on that and you believe that there's still other $2,000,000,000,000 outcomes, then in many ways, late stage could be a more attractive risk adjusted bet than than the early stage. That's what a lot of LPs... It's a consensus view at this point. It's not even a contrarian view, which is quite shocking just from five years ago.
- 51:35
We've talked a lot about, SpaceX today, but when we really broke down kind of the math on it, we're looking at the different tranches, and the early stage investors who came in in 2002 clearly had a home run, like exponential outcome. They did phenomenal. But when you look at the people who came in fifteen years later in 2017, and had the benefit of Starlink and just really significant credibility that the company had experienced post that time period, they got a return like 75X.
- 52:06
And the IRR math on that, because of the shorter duration and the time it took to IPO, was very similar to what you were getting as an early stage investor. And we'll take that all day long. Like, we're very happy to jump in at a point where you have product market fit. It's been derisked. And that's a very acceptable outcome to us. We don't have to shoot for the fences and be a first mover. It's just not the game that we're playing.
- 52:29
I have to point out, compliance always reminds me, disclose, disclose.